Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics
CKPT Price/Volume Stats
| Current price | $4.26 | 52-week high | $4.50 |
| Prev. close | $4.23 | 52-week low | $1.75 |
| Day low | $4.23 | Volume | 8,666,800 |
| Day high | $4.28 | Avg. volume | 2,229,480 |
| 50-day MA | $4.09 | Dividend yield | N/A |
| 200-day MA | $3.32 | Market Cap | 370.71M |
CKPT Stock Price Chart Interactive Chart >
Checkpoint Therapeutics, Inc. (CKPT) Company Bio
Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
CKPT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CKPT Price Returns
| 1-mo | 2.90% |
| 3-mo | 72.47% |
| 6-mo | 7.30% |
| 1-year | 125.40% |
| 3-year | -68.21% |
| 5-year | -80.37% |
| YTD | 33.13% |
| 2024 | 39.74% |
| 2023 | -55.19% |
| 2022 | -83.57% |
| 2021 | 17.36% |
| 2020 | 54.07% |